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Abbreviations 
EEG: electroencephalogram; EMG: electromyogram; IR: infra red; NREM sleep: non 
rapid-eye movement sleep; RW: running wheel; SWA: slow wave activity. 
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Abstract 
We tested the hypothesis that the effects of GABAergic agonists on behavior and 
the electroencephalogram (EEG) result from an increased regional synchronization in 
cortical circuits. The relationship between regional EEG topography, EEG 
synchronization and alteration of behavior was investigated by administering male 
C57BL/6 mice (n=7) a high, 3 mg/kg i.p. dose of muscimol, a selective GABAA agonist. 
Parietal and frontal cortical EEG, electromyogram, infra red- and running wheel-activity 
were recorded for 3 h before and 9 h after injection. 
Muscimol consistently elicited biphasic behavioral changes. Initially, it induced a 
catalepsy-like state lasting 96.0 ± 12.4 min. This state was followed by a hyperactivity 
period of 49.7 ± 5.4 min, during which the mice engaged in vigorous wheel running. 
During catalepsy, the EEG exhibited high amplitude waves which showed a consistent 
phase relationship between the frontal and parietal derivation. Moreover, the typical 
regional differences between the EEG spectra of the two derivations were abolished, 
and a redistribution of EEG power towards lower frequencies (<3 Hz) occurred in both 
derivations. In contrast, during hyperactivity the parietal EEG was dominated by theta-
activity (7-9 Hz), which is typical for running behavior, while high amplitude slow waves, 
resembling the normal NREM sleep EEG pattern, predominated in the frontal EEG.  
The data indicate that the GABAergic system is involved in the regulation of 
cortical synchronization of neuronal activity and suggest a link between regional EEG 
synchronization and behavioral states.  
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Introduction 
Electrical activity of the brain is determined by specific interactions between 
billions of excitatory and inhibitory neurons of the neocortex and subcortical structures. 
All major oscillations in the electroencephalogram (EEG), namely delta, theta, spindle 
and gamma frequencies, arise from synchronous neuronal activity in the neocortex, 
thalamus, hippocampus and other brain structures, where GABAergic interneurons play 
an important role (Steriade et al., 1990, von Krosigk et al., 1993, Steriade and Amzica, 
1998, Bland et al., 1999, Chapman and Lacaille, 1999).  
Regional EEG differences are present during waking and sleep in humans and 
rodents. These differences are enhanced after prolonged wakefulness and are thought 
to reflect use-dependent processes (Huber et al., 2000, Vyazovskiy et al., 2000, 
Vyazovskiy et al., 2006). Regional EEG dynamics during sleep have not only a 
functional but also a morphological basis. Thus, EEG recordings in acallosal mice which 
have enhanced neocortical connectivity in the rostral part of the hemisphere due to the 
Probst bundle, showed higher frontal EEG power at approximately 1 Hz at the expense 
of the remaining delta frequencies (Vyazovskiy and Tobler, 2005). Based on such 
results we proposed that there is a link between local changes of EEG power and 
regional neuronal synchronization (Vyazovskiy and Tobler, 2005).  
The level of regional synchronization might be an important factor underlying 
vigilance. In contrast to waking, during which cortical activity is activated, behavioral 
states characterized by high EEG synchrony, such as non-rapid eye movement (NREM) 
sleep or absence seizures, are accompanied by reduced responsiveness, immobility 
and loss of consciousness. Neurophysiological mechanisms underlying the relationship 
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between regional synchronization and the behavioral state are unresolved, though there 
is considerable evidence that GABA-mediated inhibition might be involved.  
GABAergic agonists elicit sedation and sleep (Nelson et al., 2002, Reynolds et 
al., 2003, Mohler, 2006, Rudolph and Mohler, 2006), but the neurophysiologic 
mechanisms underlying their hypnotic properties remain unknown (Nelson et al., 2002). 
A large body of evidence suggests that the sedative and/or hypnotic action of GABAA 
agonists is associated with increased cortical synchronization in the low EEG 
frequencies. Thus, in rats muscimol induced sedation and catalepsy (reviewed in 
DeFeudis, 1980) and an increase of low EEG frequencies (2-6 Hz) in NREM sleep 
(Lancel et al., 1996, Lancel et al., 1997). These findings are consistent with EEG 
alterations found in an absence epilepsy-prone rat strain (WAG\Rij), where icv muscimol 
induced a dose-dependent abnormal EEG pattern consisting of slow waves and spikes 
which persisted for several hours (Peeters et al., 1989). Bilaterally synchronous spike-
waves appeared after systemic administration of muscimol in the cat (Fariello et al., 
1981), while in the baboon Papio papio, muscimol induced spike-wave complexes 
(Pedley et al., 1979) similar to the EEG changes elicited by 5 mg/kg muscimol in 
patients suffering from Huntington's disease (Shoulson et al., 1978). Other behavioral 
effects of muscimol were prolongation of propofol-induced anesthesia in mice (Irifune et 
al., 2003), and a dose-dependent increase in the duration of spontaneous petit mal-like 
seizures in the rat (Vergnes et al., 1984). Taken together, these observations suggest 
that neuronal synchronization, underlying the generation of low EEG frequencies is 
markedly increased after administration of potent GABAA receptor agonists.  
7 
We tested the hypothesis that behavioral alterations, such as sedation and 
reduced locomotion elicited by GABAA agonists, are accompanied by changes in 
regional EEG topography and EEG synchronization in low frequencies. We used 
muscimol because it is a powerful GABAA agonist and tested its effects on behavior and 
the EEG in mice.  
8 
Experimental procedures 
Animals. The experiments were performed in accordance with the European 
Communities Council Directive of 24 November 1986 (86/609/EEC) and were approved 
by the Cantonal Veterinary Office of Zurich. All efforts were made to minimize the 
number of mice used and their suffering. Male C57BL/6 mice (n=7) (Harlan 
Netherlands, B.V.) were operated at 12.6 ± 0.2 weeks (weighing 25.5 ± 0.6 g at 
surgery). The mice were kept individually in Macrolon cages (36 x 20 x 35 cm), 
equipped with running wheels (Vyazovskiy et al., 2006) to investigate voluntary 
locomotor activity. Food and water were available ad libitum, and the mice were 
maintained on a 12 h light - 12 h dark cycle (daylight type fluorescent tubes, 58 W, 
approximately 30 lux) at a constant ambient temperature (22-24°C).  
 
Surgery. Stainless steel electrodes (0-80 x 1/8; Plastics One® Inc., Roanoke, Virginia, 
USA) for EEG recording were implanted epidurally under deep anesthesia (ketamin 87 
mg/kg – xylazin 13 mg/kg, i.p.) over the right frontal cortex (2 mm anterior to bregma, 
1.5 mm lateral to the midline; Paxinos and Franklin, 2001), and over the right parietal 
cortex (3 mm posterior to bregma, 2 mm lateral to midline) and as reference over the 
cerebellum (~ 2 mm posterior to lambda, on the midline). The electrodes were 
connected to stainless steel wires and fixed to the skull with dental cement. Two gold 
wires (diameter 0.2 mm) were inserted into the neck muscles to record the 
electromyogram (EMG). After surgery the mice were connected by a fine cable to the 
amplifier via a swivel, and remained connected during the entire experiment. At least 3 
weeks were allowed for recovery and adaptation to the recording conditions.  
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Data acquisition. The EEG and EMG signals were amplified (amplification factor 
approx. 2000), conditioned by analogue filters (high-pass filter: -3 dB at 0.016 Hz; low-
pass filter: -3 dB at 40 Hz, < -35 dB at 128 Hz) sampled with 256 Hz, digitally filtered 
(EEG: low-pass FIR filter 25 Hz; EMG: band-pass FIR filter 20-50 Hz) and stored with a 
resolution of 128 Hz. Consecutive 4-s epochs were subjected to a Fast Fourier 
Transform routine and EEG power density was computed for 4-s epochs in the 
frequency range of 0.25-35.0 Hz (frequencies above 35 Hz were not analyzed).  
 
Experimental protocol and data analysis. The experimental group of mice, 
implanted with EEG electrodes (n=7, see below) was injected i.p. with vehicle and after 
at least 4 days, with 3 mg/kg muscimol. This design was chosen to avoid the potential 
long-term effects of muscimol on the EEG, precluding a reliable comparison with the 
effects of vehicle on behavior and the EEG. Muscimol (Tocris Cookson Ltd., Bristol, UK) 
was dissolved in physiological pyrogen-free saline (0.9% NaCl; vehicle). Injections 
occurred 3 h after light onset.  
The 3 mg/kg dose was chosen based on a behavioral pilot study, where the 
effects of two doses (2 mg/kg i.p., n=14, and 1 mg/kg, n=4,) were evaluated. Both doses 
reduced locomotor activity within 15 min post-injection. All mice were sedated, with eyes 
open and displaying an extended, rigid body posture and elongated tail, behaviors 
typical for a catalepsy-like state. The effect lasted between 40-150 min, recovery 
occurring more rapidly after the lower dose (30-60 min). In a few mice, muscimol 
induced myoclonic jerks of the hind limbs, as described by Menon and Vivonia, 1981. 
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Furthermore, we assessed in n=5 of the 14 mice receiving 2 mg/kg muscimol, the ability 
to respond to multimodal sensory stimuli (tapping the cage once) applied every 15 min 
during catalepsy. Arousal responses such as head or ear movements or a body jolt 
were observed in all mice. Since the aim of the study was to test the hypothesis that 
behavioral changes are related to the regional EEG pattern, we chose 3 mg/kg to make 
sure that reliable, prolonged catalepsy and hyperactivity phases would be induced. 
Continuous EEG, time-lapse video recordings, infrared (IR) - and running-wheel 
(RW)-activity recordings were obtained (n=7). RW-revolutions and activity counts were 
integrated over consecutive 1-min epochs and stored on a computer, as described 
previously (Deboer and Tobler, 2000; Chronobiology Kit, Standford Software System, 
Stanford, California). Vigilance states were visually scored for 4-s epochs on the basis 
of the raw parietal EEG, slow-wave activity (SWA, EEG power between 0.75-4.0 Hz) 
and the EMG (Tobler et al., 1997). In the first 1-2 h after muscimol administration the 
waking and NREM sleep EEG were sometimes indistinguishable. Vigilance states were 
then determined based on the EMG, IR-activity and the behavioral scoring of the video 
tapes. Epochs containing EEG artifacts in either derivation were visually identified and 
excluded from spectral analysis of both derivations (7.71.4 % of 12 h).  
 
EEG wave and cross-correlation analysis. The incidence and amplitude of 
EEG waves were investigated in the 3 h before and after injection of muscimol. EEG 
half-waves were defined based on zero-crossings of the EEG signal after band-pass 
filtering of delta frequencies (0.5-4.0 Hz; stop band edge frequencies 0.1 and 8.0 Hz, 
respectively). Wave incidence was the number of peaks detected in the filtered signal 
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within pre-defined amplitude ranges. The amplitude of EEG half-waves was assessed 
by computing the maximal or minimal voltage (positive and negative half-waves, 
respectively) between two consecutive zero-crossings. Half-waves shorter than 0.1 
seconds and < 10 µV were excluded.  
An estimate of the cross-correlation between the frontal and parietal EEG time series 
was computed based on 4-s epochs (sampling rate 128 Hz) with Matlab function xcorr. 
The sequences of correlation coefficients were obtained for all 4-s epochs during 
muscimol induced catalepsy and for all 4-s epochs in NREM sleep of the corresponding 
time interval after vehicle. Subsequently, for each 4-s epoch the time difference 
between lag = 0 of the correlation and the time lag corresponding to the highest 
correlation value within a 1-s window below or above the lag = 0 was determined.  
Before computing averages and for statistical comparisons Fisher’s z-
transformation was applied to correlation values. The software package Matlab (The 
Math Works, Inc., Natick, MA, USA) was used for data and signal analysis.  
 
Statistics. The effects of muscimol and vehicle on vigilance states and EEG spectra 
were compared within each treatment by rANOVAs with factors ‘pharmacological 
treatment’ (muscimol and vehicle) and ‘time interval’, followed by two-tailed paired t-
tests. The relationship between the duration of the hyperactivity phase or RW intensity 
and the subsequent level of SWA in NREM sleep was assessed by linear correlation 
analyses (Pearson). SAS (SAS Institute, Inc., Cary, NC, USA) was used for statistical 
analysis.  
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Results 
Biphasic behavioral effects of 3 mg/kg muscimol 
Muscimol elicited in all mice a particular order of behaviors associated with specific 
EEG patterns (Fig. 1). An initial activation lasting 13.3 ± 1.1 min was characterized by 
active movement (IR counts/min: 8.7  2.4) and short running bouts (RW counts/min: 
9.4 ± 2.6). This phase was followed by a long-lasting suppression of motor activity (IR 
counts/min: 0.09  0.05; SEM) and subsequent hyperactivity (IR counts/min: 11.5  
3.3). Based on the behavioral observations, the inactivity phase was defined as 
catalepsy. This state lasted 96 min (± 12.4; SEM, range 55-157 minutes). The 
hyperactivity phase was dominated by vigorous wheel running (RW revolutions/min: 
17.9  2.6) lasting 49.7 min (± 5.4; range: 28-69 min). The duration of catalepsy and the 
intensity of wheel running during hyperactivity were negatively correlated (n=7; r=-0.82, 
Pearson’s correlation coefficient, p=0.02). The behavior of the n=7 EEG mice, and the 
n=14 + 4 mice of the pilot experiment, changed as a function of the dose. As the dose 
was increased, inactivity (catalepsy) and hyperactivity was prolonged. Such a biphasic 
effect was never elicited by the vehicle. Thus, vehicle injection elicited a significantly 
longer initial activation than muscimol, 35.3 ± 3.1 min (p<0.001), and lower IR-activity 
(4.4 ± 1.1 counts/min, p=0.08) and RW-activity (4.7 ± 1.1 counts/min, p=0.06). During 
the time interval corresponding to hyperactivity after muscimol, locomotor activity after 
vehicle was markedly lower: IR-activity 0.05 ± 0.03 (p<0.05); RW-activity: 0.0 ± 0.0 
(p<0.001).  
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Major EEG alterations after administration of muscimol 
The main EEG feature during catalepsy was a regularly recurring high-voltage wave 
pattern on a low-voltage background (Fig. 2). These waves were similar in both 
derivations and occurred synchronously. As a result, the EEG spectrum during 
catalepsy did not show the regional differences between the frontal and parietal 
derivation observed during sleep after vehicle (Fig. 3). EEG power < 3 Hz was 
enhanced during muscimol-induced catalepsy in both derivations, while power > 4 Hz 
(parietal) or > 8 Hz (frontal) up to 35 Hz was below the values of NREM sleep after 
vehicle (Fig. 3, top panels).  
During hyperactivity, slow waves resembling NREM sleep slow waves dominated 
the frontal EEG (Fig. 2), resulting in a major increase in EEG power in the slow-wave 
range compared to the parietal derivation (Fig. 3, bottom panels). In contrast, the 
parietal EEG exhibited a pronounced peak in the theta frequency range which is 
characteristic of running behavior (Vyazovskiy et al., 2006).  
A “physiological” sleep pattern with a NREM-REM sleep alternation was re-
established approximately 2.5 h after the muscimol injection corresponding to the end of 
the hyperactivity phase (Fig. 4). SWA in NREM sleep was dramatically enhanced 
immediately after the muscimol-induced hyperactivity. This was the case for both 
derivations, but especially for the frontal EEG (Fig. 4, bottom panels). The SWA 
increase in the first hour after the hyperactivity phase (expressed relative to the pre-
injection level) was unrelated to the duration of the hyperactivity phase or to the amount 
of RW-activity (correlation coefficients for duration of hyperactivity: parietal, r=0.12, 
p=0.8; frontal, -0.31, p=0.5; RW-activity: parietal, r=0.41, p=0.4; frontal, -0.36, p=0.4). 
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The phase relationship between slow waves in the frontal and parietal EEG was 
enhanced after muscimol 
A striking finding was the synchronous occurrence of high-amplitude waves within both 
derivations during catalepsy (Fig. 2). We therefore investigated the amplitude 
distribution and phase-relationship of EEG waves between the two EEG derivations. 
During catalepsy, high amplitude half-waves were more abundant than during pre-
injection NREM sleep in both derivations (Fig. 5). During the muscimol-induced 
catalepsy slow-waves in the frontal EEG showed a stable phase relationship to those of 
the parietal EEG in all 7 mice (one individual is shown in Fig. 6 A). To assess this 
relationship quantitatively and to enable comparison with baseline and post-vehicle 
NREM sleep two analyses were performed.  
First, cross-correlation functions of frontal versus (vs) parietal 4-s EEG epochs 
were computed during catalepsy as well as during NREM sleep belonging to the 
corresponding time interval following vehicle injection. Several peaks appeared on the 
cross-correlation function during catalepsy (3 peaks of high correlation can be seen in 
the illustration of a single 4-s epoch in Fig. 6 B) indicating a slow periodic occurrence of 
synchronous waves after muscimol. In contrast, such synchronous oscillatory activity 
was weak during NREM sleep (Fig. 6 B, vehicle). In most 4-s epochs the highest 
correlation was observed within lag=0 ± 1 s. To assess the strength of the correlation, 
we compared the averaged highest correlation coefficients of all 4-s NREM sleep 
epochs after vehicle with the average computed for catalepsy epochs. The correlation 
between the frontal and the parietal derivation was significantly higher during catalepsy 
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compared to NREM sleep (muscimol induced catalepsy: positive: r = 0.30 ± 0.01, 
negative: r = -0.28 ± 0.01; NREM sleep after vehicle: positive: r = 0.24 ± 0.01, negative: 
r= -0.25 ± 0.01; p<0.05 both for the comparison of positive and negative r-values; paired 
t-test after Fisher z-transformation).  
To investigate the phase relationship between the frontal and parietal waves in 
more detail, the distribution of time-lags of the maximal value of the cross-correlation 
function was computed (Fig. 6 D). After muscimol a single peak was apparent at -0.065 
s, indicating that on average slow waves in the parietal derivation were delayed relative 
to the frontal waves. In contrast, after vehicle as well as during baseline NREM sleep 
before the injection (not shown), the distribution of the lags was bimodal with peaks at 
lag ± 0.125 s. Thus, a subset of frontal EEG waves occurred consistently before or 
after the waves in the parietal EEG, indicating that slow waves originated in some cases 
in the frontal regions while in others they originated in the parietal derivation. A 
considerable number of waves occurred simultaneously in both derivations (lag = 0). A 
redistribution towards an increased number of short lags at the expense of longer lags 
was apparent after muscimol compared to vehicle (Fig. 6 D).  
Secondly, because muscimol induced typical high amplitude slow waves (see 
Fig. 2 and 6 A), we performed a single wave analysis to determine the shortest time 
difference between the peaks of high-amplitude waves (>100µV) of the frontal and 
parietal EEG (Fig. 6 C). The mean difference in occurrence of the frontal and parietal 
waves (independently of whether there was an advance or a delay), was after muscimol 
shorter than after vehicle (positive half-wave peaks by 26.0  ± 2.5 % SEM; negative 
half-wave peaks by 26.9 ±2.5 %). 
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  We next investigated whether during muscimol-induced catalepsy the frontal 
high-amplitude waves occurred consistently earlier than in the parietal derivation.  
Positive half-wave peaks of the frontal waves on average preceded the positive peaks 
of the parietal derivation by 83.2 ± 9.2 ms. In contrast, after vehicle the time difference 
between wave occurrence showed considerable variability (10.4 ± 16.6. ms) and was 
significantly smaller (muscimol vs vehicle: p<0.01, paired t-test), indicating that after 
muscimol the phase relationship between the EEG waves of the two derivations was 
more stable. 
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Discussion  
We investigated the association between regional EEG topography and EEG 
synchronization with behavioral states after peripheral administration of a high dose of 
the GABAA agonist muscimol. This model was well suited because muscimol 
consistently elicited a succession of two behavioral states: a profound initial motor 
depression, resembling a catalepsy-like state, followed by a highly activated state 
characterized by robust wheel running.  
We tested the hypothesis that these two pharmacologically induced behavioral 
states are associated with a distinct regional EEG pattern. Specifically, we expected that 
in analogy to other quiescent states, such as sleep, the muscimol induced sedation 
would be associated with increased regional EEG synchronization. Consistent with our 
hypothesis, we found that during the initial catalepsy-like state, regional EEG differences 
were virtually abolished. This was a result of the strikingly similar frontal and parietal 
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EEG pattern. The high-amplitude waves dominating the EEG during this state, showed a 
tighter phase-relationship between the regions. Taken together, it seems that the 
sedative effects of GABAA agonists and GABAA modulators are related to an increased 
global synchrony of cortical neuronal activity. These results are consistent with the 
increased EEG power in the slow-wave range, high-amplitude synchronous EEG waves 
or spikes observed in the rat (Peeters et al., 1989, Lancel et al., 1996, Lancel et al., 
1997), in cats (Fariello et al., 1981), and in baboon Papio papio (Pedley et al., 1979). 
 The catalepsy-like phase, characterized by immobility and abolition of regional 
EEG differences, was followed by a hyperactivity phase during which the mice 
consistently engaged in wheel running. The cortical EEG pattern between the frontal 
and parietal derivation became remarkably dissociated (Fig. 2 and 3). Thus, the parietal 
EEG exhibited high levels of theta-activity, typical for running (Vyazovskiy et al., 2006), 
while the frontal slow waves resembled the NREM sleep EEG (Fig. 2). The succession 
of the depressed and hyperactivity phase could result from a disbalance between 
excitatory and inhibitory mechanisms.  
Muscimol elicited a dramatic increase of SWA during both the catalepsy and 
hyperactivity phase. However, during sleep following the hyperactivity phase, SWA was 
still massively above the levels (a 2-3 fold increase) encountered at the beginning of the 
light period  (Fig. 4). While the high SWA level at light onset is the consequence of the 
considerable amount of spontaneous waking towards the end of the dark period, the 
remarkable muscimol-induced SWA increase occurred after only a short period of 
hyperactivity. In contrast to the well-known correlation between waking and SWA 
(Huber et al., 1999, Franken et al., 2001, Vyazovskiy et al., 2006), the level of SWA at 
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the onset of the recovery phase and the duration of the preceding hyperactivity phase 
were not correlated. The high SWA level immediately after the hyperactivity phase when 
NREM-REM sleep cycles reappeared (Fig. 4) and its progressive decline to pre-
injection levels, suggests that normal physiological sleep is necessary to dissipate the 
sleep pressure which apparently accumulated, despite the muscimol induced slow 
waves. Consistent with this interpretation, the time course of SWA during recovery after 
muscimol induced hyperactivity resembles recovery after sleep deprivation.  
Neuronal mechanisms underlying high-amplitude synchronous waves induced by 
muscimol or by THIP, another GABAA agonist (Vyazovskiy et al., 2005) are unknown. 
Inhibitory connections play a crucial role in the generation and synchronization of 
activity in the thalamocortical network (McCormick, 1992, Kim et al., 1997). It is possible 
that high-amplitude waves induced by GABAA agonists arise from the same basic 
phenomenon - the slow cortical oscillation - as slow waves during sleep (Steriade et al., 
1993b, Steriade and Amzica, 1998). The synchronous occurrence of high-amplitude 
slow waves across cortical areas elicited by muscimol is consistent with recent data 
suggesting an important role of inhibitory neurons in the large-scale synchronization of 
the slow oscillation (Volgushev et al., 2006). In addition to the intracortical synchronizing 
mechanisms, subcortical structures might play an important role in the generation of the 
EEG pattern after muscimol and THIP. Thus the stimulation of the pedunculopontine 
tegmental nucleus or locus coeruleus blocked cyclic hyperpolarization-depolarization 
components of the slow oscillations, leading to EEG activation, thereby increasing 
power in faster frequencies and lowering power between 0-8 Hz (Steriade et al., 1993a). 
Our results are consistent with the notion that EEG synchronization is associated with 
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high values of SWA. Muscimol injection led to a redistribution of spectral EEG power 
towards lower EEG frequencies at the expense of higher frequencies above 4-8 Hz. 
Muscimol may act both in the neocortex, where it plays a role in synchronization of the 
slow cortical oscillation, and at subcortical structures which maintain the cortex in an 
activated state.  
In conclusion, we demonstrate that muscimol abolished regional differences and 
enhanced phase-relationship between EEG waves in the two cortical regions. These 
results suggest that GABAergic mechanisms play an important role in regional cortical 
synchronization. In addition, the global level of synchrony in neocortical networks might 
determine behavioral states. 
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Figure legends 
Figure 1. Representative example of slow wave activity (SWA, EEG power between 
0.75-4.0 Hz) of the parietal and frontal derivation, EMG variance and locomotor activity 
(infra red: IR and running wheel: RW) for the 4 h following administration of muscimol (3 
mg/kg, i.p.). Bars in the top three panels represent 1-min median values (slow-wave 
activity and EMG variance). Four phases are delimited by vertical lines within panel 4 
(IR) based on the presence/absence of IR-activity: (a) initial activation, (b) catalepsy, (c) 
hyperactivity and (d) recovery.   
 
Figure 2. Examples of EEG (parietal and frontal derivation) and EMG traces in NREM 
sleep and waking before muscimol injection, and during the muscimol-induced 
catalepsy and hyperactivity phase (after injection). Filter settings for the EEG: high-pass 
filter: -3 dB at 0.016 Hz; low-pass filter: -3 dB at 40 Hz. Catalepsy is characterized in 
both derivations by sporadic waves on a low voltage background and a low EMG. 
During the hyperactivity phase, theta-activity is evident in the parietal derivation, while 
slow waves predominate in the frontal cortex.   
 
Figure 3. Top: EEG power density in NREM sleep computed for the time interval after 
vehicle (left) corresponding to the catalepsy interval (right). Bottom: EEG power density 
during waking after vehicle injection and during the hyperactivity phase. Mean values 
(n=7). Horizontal lines below the curves indicate frequency bins that differed 
significantly between the derivations, as well as the effect of treatment (paired t-tests on 
log-transformed values, p<0.05). 
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Figure 4. Time course of vigilance states and slow wave activity (SWA, EEG power 
between 0.5-4.0 Hz) in NREM sleep after sleep onset (five consecutive 1-h intervals) 
following vehicle injection or after the muscimol-induced hyperactivity phase. SWA is 
represented as % of mean SWA in NREM sleep computed for 5 h after vehicle injection 
(frontal (F), parietal (P) derivation). Data are mean values ( SEM; n=7). Triangles 
above the curves: effect of treatment in each derivation. Triangles below the curves: 
comparison between the frontal and the parietal EEG (post-hoc paired t-tests when 
significance was reached after rANOVA, factor ‘treatment’ or interaction ‘treatment x ‘1-
h interval’, p<0.05). Orientation of triangles indicates the direction of deviation from 
power in the parietal EEG. Note different y-axis scaling for vehicle and muscimol.  
 
Figure 5. Amplitude of half-wave distribution (band-pass filter of delta frequencies (0.5-
4 Hz)) in NREM sleep before the muscimol injection compared to muscimol-induced 
catalepsy expressed as percentage of total number of half-waves within the 
corresponding NREM sleep, or catalepsy. Mean values (logarithmic scale; SEM; n=7) 
for the parietal and frontal derivation. Half-waves shorter than 0.1 sec and < 10 µV were 
excluded. The number of half-waves was computed for 50 µV-bins, and plotted at bin 
midpoint expressed as percentage of the total number of half-waves. Triangles indicate 
differences between the curves (p<0.05, Sidak test) and their orientation the direction of 
the difference.   
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Figure 6. A: Representative examples of the NREM sleep EEG after vehicle and during 
muscimol induced catalepsy (4-s epochs). B: Cross-correlation function (frontal vs 
parietal EEG) for the epochs illustrated in A. The earlier occurrence of the frontal waves 
can be seen in the negative lag of the highest correlation value. C: Single-wave analysis 
of temporal relationship between frontal and parietal high-amplitude waves: mean 
shortest time difference between the peaks of high-amplitude waves (>100µV) of the 
frontal and parietal derivation occurring during NREM sleep after vehicle (V) and 
muscimol-induced catalepsy (M). Mean values (SEM; n=7). Triangles indicate 
significant difference between treatment (p<0.05, paired t-test). D: Distribution of time-
lags (mean  SEM; n=7 mice. Expressed as percentage of total number of analyzed 4-s 
epochs, i.e. total number of lags) of the highest correlation coefficient within a 1-s 
window below or above the lag = 0 during catalepsy (muscimol) and NREM sleep 
(vehicle). Triangles above indicate time-lag bins (resolution 1/16 s) where treatments 
differed significantly and triangle orientation indicates the direction of difference from 
vehicle (paired t-test, p<0.05 after significance in ANOVA, interaction factors ‘treatment’ 
x ‘time-lag’).   
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